Dear Spiral user, We’re pleased to introduce Helix, https://helix.imperial.ac.uk/ Imperial’s new repository for research datasets. Please use Helix for all future dataset deposits. There is no change to Spiral -continue depositing as usual. For queries, contact the Research Data Management team at rdm-enquiries@imperial.ac.uk. Kind regards, the Spiral Team.
 
1500TiP REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design
File(s)
Author(s)
Ghorani, E
Quartagno, M
Blackhall, F
Gilbert, DC
O'Brien, MER
Type
Conference Paper
Date Issued
2023-10-01
Date Acceptance
2023-10-01
Citation
Annals of Oncology, 2023, 34, pp.S845-S845
URI
DOI
ISSN
0923-7534
Publisher
Elsevier
Start Page
S845
End Page
S845
Journal / Book Title
Annals of Oncology
Volume
34
Copyright Statement
© 2023 European Society for Medical Oncology. Published by Elsevier Inc. All rights reserved. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
License URL
Source
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
Subjects
Life Sciences & Biomedicine
Oncology
Science & Technology
Publication Status
Published
Start Date
2023-10-20
Finish Date
2023-10-24
Coverage Spatial
Barcelona, Spain